showing 5927 abstracts from year 2018
filter abstracts
| Details |
title |
year |
| Details |
TUMOR BIOLOGY: Angiogenesis Inhibitors and Stimulators #1 A kinome-wide CRI... |
2018 |
| Details |
tumor cells mediate vascular mimicry driving anti-angio- genic therapy (AA... |
2018 |
| Details |
#3 Metronomic chemotherapy with cyclophosphamide (Cy) and the repo- sitione... |
2018 |
| Details |
#4 Antitumor activity of DLX1008, a single chain antibody fragment bind- in... |
2018 |
| Details |
#5 The histone acetyltransferase inhibitor CPTH6 impairs tumor angio- genes... |
2018 |
| Details |
#6 Role of Notch signaling in bevacizumab-induced vascular normaliza- tion ... |
2018 |
| Details |
#7 Platinum resistance in epithelial ovarian cancer is dependent on a PDGFR... |
2018 |
| Details |
#9 Effcacyandfunctionalstudyoftetraarsenicoxideasananticancerdrug in cervic... |
2018 |
| Details |
#10 Evaluation of metronomic chemotherapy regimens in preclinical or- thoto... |
2018 |
| Details |
#11 Antitumor activity of lenvatinib in the renal cell carcinoma cell line ... |
2018 |
| Details |
#12 Antitumoractivityoflenvatinibincombinationwitheverolimusoran anti-PD1 a... |
2018 |
| Details |
dependent phenom- enon.... |
2018 |
| Details |
/P300 binding inhibitors.... |
2018 |
| Details |
contributes to tumor angiogenesis through regulation of IL-6 and CCL2 in o... |
2018 |
| Details |
#16 A wide-spectrum analysis of angiogenesis-related factors in ovarian can... |
2018 |
| Details |
#17 Inhibition of LRG1 normalizes tumor vessels and improves effcacy of can... |
2018 |
| Details |
#18 MMP9 inhibition in mouse models of breast cancer: Therapeutic syn- ergy... |
2018 |
| Details |
#19 Trastuzumab resistance accompanies vasculogenic mimicry in HER2- positi... |
2018 |
| Details |
#20 Inhibition of mutant EGFR in NSCLC promotes endothelin-1-medi- ated NSC... |
2018 |
| Details |
TUMOR BIOLOGY: Breast Cancer Metastasis #21 p66ShcAisacontextualbreastcance... |
2018 |
1 2 3 4 5 6 7 8 ...297 Next